|
|
|
|
| You are here: BCU: Her2 Testing in Breast Cancer Management: Concordance Between Local and Central Laboratory HER2 Testing: Related publications |
|||||
Anderson S et al. Concordance between local labs and a central lab using FISH and IHC for HER2 testing. Breast Cancer Res Treat 2002;Abstract 235. Cianciulli AM et al. Contribution of fluorescence in situ hybridization to immunohistochemistry for the evaluation of HER-2 in breast cancer. Cancer Genet Cytogenet 2002;133(1):66-71. Abstract. Gancberg D et al. Evaluation of HER-2/NEU protein expression in breast cancer by immunohistochemistry: An interlaboratory study assessing the reproducibility of HER-2/NEU testing. Breast Cancer Res Treat 2002;74(2):113-20 Abstract. Hsu CY et al. Interobserver reproducibility of Her-2/neu protein overexpression in invasive breast carcinoma using the DAKO HercepTestTM. Am J Clin Pathol 2002;118(5):693-8. Abstract. Larsimont D et al. HER-2/neu evaluation by immunohistochemistry and fluorescence in situ hybridization in breast cancer: implications for daily laboratory practice. Anticancer Res 2002;22(4):2485-90. Abstract. McCormick SR et al. HER2 assessment by immunohistochemical analysis and fluorescence in situ hybridization: comparison of HercepTestTM and PathVysion commercial assays. Am J Clin Pathol 2002;117(6):935-43. Abstract Owens MA. Correlation of HER-2/neu immunohistochemistry with fluorescence in situ hybridization in 3,568 breast cancers. Breast Cancer Res Treat 2002;Abstract 236. Persons DL et al. Fluorescence in situ hybridization (FISH) for detection of HER-2/neu amplification in breast cancer: A multicenter portability study. Ann Clin Lab Sci 2000;30(1):41-8. Abstract. Santinelli A et al. Immunohistochemical evaluation of HER-2/neu expression in infiltrating breast carcinoma: a study of reproducibility. Anal Quant Cytol Histol 2002;24(1):54-62. Abstract. Thomson TA et al. HER-2/neu in breast cancer: Interobserver variability and performance of immunohistochemistry with 4 antibodies compared with fluorescent in situ hybridization. Mod Pathol 2001;14(11):1079-86. Abstract. Zujewski JA. "Build quality in" — HER2 testing in the real world. J Natl Cancer Inst 2002;94(11):788-9. Abstract.
|